Daily Tech Briefing
AI 科技速览
每天 5 分钟内学习 AI。获取最新的人工智能新闻,理解其重要性,并学习如何将其应用于您的工作。
CNBC AI · 2026/7/22 01:17:37

Trump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production
AI 中文解读
特朗普宣布对进口仿制药征收高额关税,但给了制药企业两年的“缓冲期”,从2026年8月到2028年8月免税,之后税率将飙升至100%,再一年后达到200%。这个看似矛盾的政策,核心目的是逼迫全球药企把生产线搬到美国本土——要么现在转移,两年后免遭重税;要么继续进口,届时成本翻倍。
对美国老百姓来说,短期内仿制药价格可能不会马上上涨,因为免税窗口期还在。但长远看,如果药企真把工厂迁回美国,药品供应链会更安全,不再依赖海外供应;可代价是劳动力成本上升,最终药价可能还是比现在贵。对印度、中国等仿制药出口大国,这无疑是巨大冲击,它们要么在美国建厂,要么失去大部分市场份额。这项政策打着“振兴美国制造”的旗号,但普通患者未来买药可能要多掏钱了。
Skip NavigationMarketsPre-MarketsU.S. MarketsEurope MarketsChina MarketsAsia MarketsWorld MarketsCurrenciesPrediction MarketsCryptocurrencyFutures & CommoditiesBondsFunds & ETFsBusinessEconomyFinanceHealth & ScienceMediaReal EstateEnergyClimateTransportationInvestigationsIndustrialsRetailWealthSportsLifeSmall BusinessInvestingPersonal FinanceFintechFinancial AdvisorsOptions ActionETF StreetBuffett ArchiveEarningsTrader TalkTechCybersecurityAIEnterpriseInternetMediaMobileSocial MediaCNBC Disruptor 50Tech GuidePoliticsWhite HousePolicyDefenseCongressExpanding OpportunityEurope PoliticsChina PoliticsAsia PoliticsWorld PoliticsVideoLatest VideoFull EpisodesLivestreamTop VideoLive AudioEurope TVAsia TVCNBC PodcastsCEO InterviewsDigital OriginalsWatchlistInvesting ClubTrust PortfolioAnalysisTrade AlertsMeeting VideosHomestretchJim's ColumnsEducationSubscribePROPro NewsJosh BrownMike SantoliCalls of the DayMy PortfolioLivestreamFull EpisodesStock ScreenerMarket ForecastOptions InvestingChart InvestingSubscribeLivestreamMenuMake ItselectUSAINTLLivestreamSearch quotes, news & videosLivestreamWatchlistSIGN INCreate free accountMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting ClubPROLivestreamMenu
(function() {
const userMembershipOnLastVisit = localStorage.getItem("cnbcMeta__cachedUserMembership");
if (!userMembershipOnLastVisit) {
// If no user membership is stored, user is likely not logged in.
// These users will typically see the banner.
return;
}
const { isPro, isInvestingClubUser } = JSON.parse(userMembershipOnLastVisit);
if (!(isPro || isInvestingClubUser)) {
// We’re rendering the top banner for users who are not pro or investing club members.
return;
}
// Hide the banner for pro and investing club users.
const style = document.createElement("style");
style.id = "top-banner-placeholder-style";
style.innerHTML = "[data-top-banner-placeholder] { display: none; }";
document.head.appendChild(style);
})()
EconomyTrump plans steep tariffs on generic drugs starting in 2028 to spur U.S. production Published Tue, Jul 21 20269:17 PM EDTAnniek Bao@in/anniek-bao-460a48107/@anniekbyxWATCH LIVEKey PointsTrump said generic drugs imported into the U.S. will face zero tariffs for two years from August 1, before a 100% levy takes effect in August 2028 and rises to 200% a year later.The phased schedule is intended to push generic drugmakers to move production onshore, he said.U.S. President Donald Trump signs an executive order on researching the effects of psychedelic drugs in medical treatment for veterans, on Saturday, April 18, 2026 in the Oval Office at the White House in Washington, D.C. The Washington Post | The Washington Post | Getty ImagesPresident Donald Trump said generic drugs imported into the U.S. will face zero tariffs for two years starting August 1, before a 100% levy takes effect in August 2028 and rises to 200% a year later.The phased schedule is intended to push generic drugmakers to move production onshore, Trump said in a social media post Tuesday, describing the escalation as "a penalty" for companies that don't build plants and facilities in the U.S. within the grace period. Tariffs on patented and branded drugs will remain unchanged, Trump said. The president imposed a 100% levy on patented pharmaceutical products and ingredients under Section 232 on April 2, while exempting generic drugs, biosimilars, and related ingredients. Larger drugmakers were given 120 days before the 100% tariff rate goes into effect, and smaller drugmakers, which rely on contract manufacturers, had 180 days before that rate hits. More than a dozen major drugmakers, including Eli Lilly, Pfizer and Novo Nordisk, have struck deals with Trump to lower the prices of new and existing medicines. Those agreements ar
分享
阅读原文 ↗